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| INTRODUC TI ON
Neuroblastoma (NB), a tumor of the sympathetic nervous system, is the most common extracranial solid tumor in children. The majority of patients are assigned to the high-risk group based on their age at diagnosis, stage, histology, MYCN status and DNA ploidy.
NB prognosis remains poor with a 5-year event-free survival rate of approximately 40% despite intensive myeloablative chemotherapy and bone marrow transplantation. 1 Current therapeutic regimens frequently induce a minimal residual disease condition, and relapsed tumors are often refractory towards salvage chemotherapy because of multidrug resistance. 2, 3 In these patients, immunotherapy may provide an additional therapeutic strategy. 4, 5 Many mechanisms underlying how tumors escape tumor immunosurveillance have been proposed. DC play a crucial role in the initiation of both antitumor immunity and immunological tolerance.
6,7
The immunogenic and tolerogenic functions of DC originate from distinct stages of differentiation. 8 Tolerogenic DC are characterized by low expression of costimulatory molecules, low production of IL-12 and resistance to maturation in response to danger signals such as Toll-like receptor ligands. 9 In humans, DC represent less than 1% of circulating cells in peripheral blood and can be obtained in vitro from monocytes through a combination of factors and cytokines. 10 It has been shown that tumor cells produce various cytokines and small molecules as well as suppressing human DC differentiation and functions. For example, renal cell carcinoma secretes IL-6 and macrophage colony-stimulating factor, and induces macrophages, thereby inhibiting DC differentiation. 11 Leukemic cell products induce secretion of IL-1β by monocytes and interfere with differentiation of human DC. 12,13 IL-10, TGF-β1 and VEGF are also reported to modulate DC functions. [14] [15] [16] [17] In addition to cytokines, gangliosides from neuroblastoma and melanoma impair DC differentiation from monocytes. 18, 19 These findings suggest that DC may be polarized to a tolerogenic phenotype through tumor cell-derived soluble factors in the tumor microenvironment. However, the mechanism through which tumor cell-derived soluble factors suppress antitumor im- effect against various types of malignant tumors. 21, 22 In murine liver and lung metastasis models, i.v. administration of αGalCer-pulsed DC activates iNKT cells and eradicates the established metastatic tumor foci. 23 However, the abovementioned functions of DC are suppressed in the tumor microenvironment, and whether tolerogenic DC can stimulate iNKT cells remains unclear.
In this study, we investigated the effects of NB cell line-derived for an additional day with OK-432 in the presence or absence of 25% (v/v) NB-sup (NLF or GOTO cells). On day 7, the culture supernatants were harvested. F, Amounts of IL-12 secreted from mature DC were measured by ELISA. P-values were calculated by the paired t-test (C, D and F). *P < 0.05, **P < 0.01 and ***P < 0.001. CBA, cytometric bead array; DC, dendritic cells; ELISA, enzyme-linked immunosorbent assay; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL, interleukin; TNF, tumor necrosis factor The surface phenotypes of PBMC and cultured cells were determined by a FACSVerse (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed using the FlowJo software program (Flowjo LLC). Live cells were analyzed by gating out propidium iodide-stained cells.
| Preparation of immature DC
Peripheral blood was collected from healthy volunteers after obtaining their informed consent. All experiments were performed in accordance with the Declaration of Helsinki and approved by the institutional review board. PBMC were separated by density gradient centrifugation using Ficoll-Paque Plus (GE Healthcare, Fairfield, CT, USA). To generate moDC, the monocytes were purified using CD14
MicroBeads and cultured for 6 days in 12-well plates (1 × 10 6 cells/ mL) using complete RPMI-1640 medium (containing l-glutamine, penicillin G, streptomycin, 2-mercaptoethanol, HEPES buffer and 10% heat-inactivated FCS) supplemented with 50 ng/mL recombinant human IL-4 and 800 U/mL GM-CSF.
| Tumor cell supernatants
The human NB cell line SH-SY5Y was kindly provided by Dr A.
Nakagawara (Chiba, Japan 
| Maturation of DC
After 6 days of culture, immature DC induced by the abovementioned method were cultured for an additional day with 0.1 KE/mL OK-432.
On day 7, the cells and culture supernatants were harvested. 
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| Activation of iNKT cells
Peripheral blood mononuclear cells were cultured in complete RPMI-1640 medium in the presence of 100 U/mL recombinant IL-2 and 200 ng/mL αGalCer for 7 days. iNKT cells were purified using an FITC- 
| Cytokine measurement
Culture supernatants were collected and stored at −80°C until measurements of cytokine levels. The levels of IFN-γ, IL-12p70
and TGF-β1 were determined using ELISA kits (BD Biosciences).
IL-1β, IL-4, IL-6, IL-10, TNF-α and VEGF levels were determined using a BD Cytometric Bead Array System (BD Biosciences).
| Statistical analyses
Statistical analysis was performed using GraphPad Prism software, version 5.04. Error bars represent the standard derivation in all graphs. All P-values were two-sided, and P-values of less than 0.05
were considered to be statistically significant.
| RE SULTS
| Effects of culture supernatant from NB cell lines (NB-sup) on DC differentiation
Monocytes isolated from healthy volunteers were incubated with IL-4 (50 ng/mL) and GM-CSF (800 U/mL) in the presence or absence of 25% (v/v) NB-sup (NLF, GOTO or SH-SY5Y cells). After 6 days of culture, immature DC were cultured for an additional day with 0.1 KE/mL OK-432. On day 7, the cells and culture supernatants were harvested ( Figure 1A ).
In the control culture, mature DC lost their CD14 expression (MFI, 7.4 ± 3.4) and showed upregulated CD1a expression (MFI, 1127 ± 499). However, the presence of GOTO cell supernatant (GOTO-sup) and NLF cell supernatant (NLF-sup) partially blocked both the downregulation of CD14 (135 ± 115 in GOTO-sup and 253 ± 188 in NLF-sup) and upregulation of CD1a (425 ± 381 in GOTO-sup and 337 ± 248 in NLF-sup), whereas the SH-SY5Y cell supernatant (SH-SY5Y-sup) had no effect ( Figure 1B ,C, and Table 1 ).
Furthermore, GOTO-sup and NLF-sup downregulated CD40, CD83
and CD86 expression and upregulated CD16, PD-L1 and HLA-DR (Table 1 , Figures S1,S2 ). We next measured the cytokine secretion by DC following stimulation with OK-432. Exposures to NLF-sup and GOTO-sup dramatically decreased IL-12 and TNF-α production, whereas no significant changes were found in the levels of IL-10
( Figure 1D ).
To demonstrate the direct effect of the culture supernatant In addition, IL-12 production after stimulation with OK-432 was clearly decreased ( Figure 2C ). TNF-α production tended to decrease in 1% (v/v) and 5% (v/v) NLF-sup groups, but not significantly. The other cell surface profiles of mature DC are shown in Table 2 and Figures S3 and S4.
Based on these results, we concluded that NLF-sup and GOTO-sup inhibited the differentiation of monocytes to DC and decreased IL-12 and 
| Analyses of soluble factors in NB-sup
Some tumor cells produce pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α, which are associated with tumor development and progression.
27 IL-10, TGF-β1 and VEGF have been reported to hamper the differentiation of DC. [14] [15] [16] [17] We measured the concentrations of these cytokines in NB-sup by the CBA. IL-1β, IL-6, TNF-α, IL-10 and TGF-β1 were not detected in NLF-sup, GOTO-sup or SH-SY5Y-sup.
VEGF was detected in the tumor cell supernatants, but its concentration was almost the same in all three cell line supernatants (NLF-sup, 403.7 pg/mL; GOTO-sup, 66.2 pg/mL; SH-SY5Y-sup, 169.8 pg/mL). 
| Cytokine production by monocytes in the presence of NB-sup
As shown in Figure 3A , monocytes isolated from healthy volunteers were incubated with IL-4 (50 ng/mL) and GM-CSF (800 U/mL) in the presence of 1% (v/v), 5% (v/v) or 25% (v/v) NB-sup (NLF, GOTO or SH-SY5Y cells). After 24 hours of incubation, the supernatants were harvested, and the levels of cytokines (IL-1β, IL-6 and IL-10) secreted from monocytes were measured by the CBA. We found that monocytes produced increased levels of IL-6 and IL-10 after stimulation with NLF-sup and GOTO-sup, whereas SH-SY5Y-sup had no effect ( Figure 3B ). Furthermore, IL-6 and IL-10 secretion from monocytes in response to NLF-sup was dose-dependent ( Figure 3C ). In contrast, IL-1β production was more than 1000 pg/mL in two of five healthy donors when cultured in the presence of 5% or 25% (v/v) NLF-sup, but the remaining three donors showed markedly less IL-1β production (<500 pg/mL).
| Effects of IL-6 on moDC
Next, we investigated the effects of IL-6 on moDC. As shown in Figure 4A , moDC were incubated in the presence or absence of recombinant human IL-6. IL-6 addition to monocyte cultures tended to decrease IL-12 production after stimulation with OK-432, but CD14 expression was comparable with that in control DC ( Figure 4B ).
We also evaluated the effects of IL-6 neutralization in the moDC culture. As shown in Figure 4C , moDC were incubated in the presence of 25% (v/v) NLF-sup with a neutralizing anti-IL-6 Ab (10 μg/ mL) or matching isotype control. IL-6 blockade in monocyte cultures with NLF-sup did not recover IL-12 production after stimulation with OK-432 ( Figure 4D ). Therefore, our data suggested that IL-6 was not the only factor that modulated DC functions.
| Cytokine production by T cells in the MLR assay with NB-sup-treated DC
Previous studies have shown that tolerogenic DC have the capacity to induce anergy in tetanus toxoid-specific memory CD4 + T cells. 14 We examined the functional activity of NB-sup-treated DC by an allogeneic MLR assay using human T cells as responders. moDC were cultured under the same conditions described in Figure 1A . On day 7, T cells were purified from PBMC using CD3 MicroBeads. Allogeneic T cells and moDC were mixed at a ratio of 5:1, and the culture supernatants were collected after 48 hours ( Figure 5A ). The IFN-γ production of allogeneic T cells after stimulation with NLF-sup-treated DC was decreased significantly ( Figure 5B ).
F I G U R E 5
Cytokine production by T cells in the MLR assay with NB-suptreated DC. A, moDC were cultured under the same conditions described in Figure 1A . Allogeneic T cells and moDC were mixed at a ratio of 5:1, and the culture supernatants were collected after 48 h. B, IFN-γ concentrations in culture supernatants were measured by ELISA. P-values were calculated by the paired t-test. *P < 0.05 and **P < 0.01. DC, dendritic cells; IFN, interferon; ELISA, enzyme-linked immunosorbent assay; MLR, mixed lymphocyte reaction 
| Effect of IL-12 on IFN-γ production of iNKT cells after stimulation with αGalCer-pulsed DC
The production of IFN-γ by iNKT cells in response to αGalCer requires IL-12 produced by DC and direct contact between iNKT cells and DC through CD40/CD40L interactions. 28 Figures 1D and 2D show that IL-12 secretion by NLF-sup or GOTO-sup-treated DC was dramatically decreased compared with control DC. Figure 6B shows that the IFN-γ production of iNKT cells after stimulation with NLF-sup-treated, αGalCer-pulsed DC was reduced to 70% on average in three donors compared with control DC.
We analyzed the effect of IL-12 addition on iNKT cells stim- 
| Effect of IFN-γ on moDC
It is well known that CD40 expression on DC is needed for IL-12 production by DC. Moreover, αGalCer-pulsed DC upregulate the expression of CD40L on iNKT cells, which in turn stimulates CD40 on DC to produce IL-12 that induces IFN-γ production from iNKT cells. 29 On the other hand, IFN-γ has been previously shown to be a strong CD40 inducer. 30 Therefore, we investigated the influence of IFN-γ on moDC.
As shown in Figure 8A , IFN-γ (10 ng/mL) was added to the culture F I G U R E 6 iNKT cell activation by NB-sup-treated, αGalCer-pulsed DC. A, On day 0, PBMC were cultured with IL-2 and αGalCer for 7 days. On day 7, Vα24-FITC-stained cells were purified by autoMACS Pro Separator positive selection. The purified iNKT cells were cultured for an additional 7 days. moDC were cultured under the same conditions described in Figure 1A and 200 ng/mL αGalCer was added to the culture medium of DC on day 13. iNKT cells and moDC were mixed at a ratio of 5:1, and the supernatants were collected after 24 h. Stimulations were performed in triplicate. Three independent experiments were performed. B and C, IFN-γ and IL-4 concentrations in supernatants were measured by ELISA and the CBA. Error bars represent the standard deviation. P-values were calculated by the unpaired ttest. *P < 0.05 and **P < 0.01. D, moDC were cultured under the same conditions described in Figure 1A , and 200 ng/mL αGalCer was added to the culture medium of DC on day 6. PBMC and irradiated αGalCer-pulsed DC were co-cultured at a ratio of 10:1 for 7 days. The cells were collected and counted on day 14, and the percentages of Vα24 + Vβ11 + iNKT cells were analyzed by flow cytometry. E, Percentages and fold expansion of iNKT cells. P-values were calculated by the paired t-test. CBA, cytometric bead array; DC, dendritic cells; ELISA, enzyme-linked immunosorbent assay; FITC, fluorescein isothiocyanate; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; iNKT cells, invariant natural killer T cells; MACS, magnetic-activated cell sorting; PBMC, peripheral blood mononuclear cells; TNF, tumor necrosis factor F I G U R E 7 Effect of IL-12 on IFN-γ production by iNKT cells after stimulation with αGalCer-pulsed DC. iNKT cells and moDC were cultured under the same conditions described in Figure 6A . A, iNKT cells and moDC were mixed at a ratio of 5:1 with various concentrations of IL-12. The supernatants were collected after 24 hours. B, iNKT cells and moDC were mixed at a ratio of 5:1 with anti-IL-12p70 Ab (10 μg/mL) or isotype control mouse IgG1. The culture supernatants were collected after 24 hours. C, iNKT cells and moDC were mixed at a ratio of 5:1, and the culture supernatants were collected after 24 hours. A-C, Stimulations were performed in triplicate. Three independent experiments were performed. The IFN-γ concentration in culture supernatants was measured by an ELISA. Error bars represent the standard deviation. P-values were calculated by the unpaired t-test. *P < 0.05, **P < 0.01 and ***P < 0.001. DC, dendritic cells; ELISA, enzyme-linked immunosorbent assay; FITC, fluorescein isothiocyanate; IFN, interferon; Ig, immunoglobulin; IL, interleukin that mature tolerogenic DC had similar expression of HLA-DR, CD1a, CD80, CD83 and CD86, lower expression of CD40, and higher expression of CD14 and CD16 than control DC. Motta et al 12, 13 showed that expression of CD14, CD16 and CD68 was higher and expression of CD1a was lower in the presence of K562 cell supernatants than in their absence. Furthermore, DC activated with TNF-α had lower expression of CD80 and CD83 than control DC. 12, 13 Lindenberg et al 15 reported that IL-10-conditioned mature DC expressed lower levels of CD80, CD83 and CD86, whereas expression of PD-L1 was elevated compared with control mature DC. In terms of cytokine secretion, all three authors showed that mature tolerogenic DC released lower levels of IL-12 than control mature DC.
In the current study, we found that expression of CD14, CD16, PD-L1 and HLA-DR on GOTO-sup-and NLF-sup-treated DC was higher, and CD1a, CD40, CD83 and CD86 expression was lower than on control DC, while there was no significant difference in their expression between SH-SY5Y-sup-treated and control DC ( Figure 1B ,C, Figures S1,S2 ). In addition, the exposures to NLF-sup and GOTO-sup dramatically decreased IL-12 and TNF-α production in DC ( Figure 1D ).
Human monocytes are generally defined as CD14 + cells, whereas DC are defined as CD1a + cells. 12 When monocytes were incubated with IL-4, GM-CSF and tumor supernatants, an increase in the CD14 + population was observed on average. Despite the downregulation of CD14 and upregulation of CD1a even in the presence of NB-sup in some cases, IL-12 production was dramatically suppressed compared with control DC. These findings indicated that the expression of surface molecules on tolerogenic DC differed among individuals, while tolerogenic DC produced low levels of IL-12 in all subjects.
Next, we attempted to identify the inhibitory factors in NB-sup.
Although the tumor microenvironment has been shown to be abundant with cytokines that modulate DC functions, IL-1β, IL-6, TNF-α, IL-10 and TGF-β1 were not detected in NLF-sup or GOTO-sup. Only VEGF was detected in NB-sup, which has no inhibitory effect on DC
A, moDC were cultured under the same conditions described in Figure 1A . On day 5, IFN-γ (10 ng/mL) was added to the culture medium of moDC and 24 hours later, cells were treated with OK-432 for an additional day. On day 7, the cells and culture supernatants were harvested. B, Amounts of IL-12 secreted from mature DC were measured by ELISA, and CD40 expression in mature DC was analyzed by flow cytometry. P-values were calculated by the paired t-test. *P < 0.05. DC, dendritic cells; ELISA, enzyme-linked immunosorbent assay; IFN, interferon; IL, interleukin; MACS, magnetic-activated cell sorting; PBMC, peripheral blood mononuclear cells differentiation. Thus, these cytokines were not the factors underlying the inhibition of DC by NB cell lines.
Motta et al 12 reported that TNF-α and IL-1β production by monocytes during differentiation increases in the presence of tumor cell supernatants. Furthermore, the presence of IL-1β during monocyte differentiation partially prevents the loss of CD14 and inhibits the appearance of CD1a. Neutralization of IL-1β in such cultures partially reverses CD14 expression but is not sufficient to modify CD1a expression. We measured the amount of cytokines secreted from monocytes cultured with NB-sup ( Figure 3 ). When cultured with NLFsup or GOTO-sup, the concentration of IL-6 was more than 10 ng/mL, and that of IL-10 was approximately 100 pg/mL. In contrast, IL-1β secretion varied among individuals ( Figure 3B ), and TNF-α secretion was comparable with that in control DC (data not shown). IL-6 has been
shown to act as an immunosuppressive cytokine in DC differentiation through STAT3 activation. 33 Moreover, Bharadwaj et al 34 showed
that human pancreatic cell line BxCM contains high levels of IL-6 and G-CSF. Depleting IL-6 or G-CSF from BxCM and blocking BxCMinduced STAT3 activation reverses the DC-inhibitory properties. 34 In our study, IL-6 addition to moDC cultures decreased IL-12 production after maturation stimuli, but CD14 expression was comparable with that in control DC ( Figure 4B ). Furthermore, IL-6 blockade in monocyte cultures with NB-sup did not recover IL-12 production after stimulation with OK-432 ( Figure 4D ). Therefore, our data suggest that IL-6 may be an important factor, but not the only factor, which modulates DC functions.
We also evaluated DC functions by stimulation of iNKT cells and allogeneic T cells. iNKT cells rapidly produce high amounts of both Th1 and Th2 cytokines upon stimulation, playing an important role in autoimmunity, infections and antitumor immunity. 35 αGalCer-activated iNKT cells exert a strong antitumor effect against various types of malignant tumors. 21 iNKT cell infiltration into primary tumors serves as a prognostic factor for a favorable outcome in a subset of patients with metastatic NB. 36 However, reports have shown selective decreases in the number and functions of iNKT cells in patients with advanced cancer. 37,38 IFN-γ acts on NK cells to eliminate MHCnegative tumors and on CD8 cytotoxic T cells to kill MHC-positive tumors, resulting in tumor eradication. 39 The production of IFN-γ by iNKT cells in response to αGalCer requires IL-12 production by DC and direct contact between iNKT cells and DC through CD40/CD40L
interactions. 28, 29 We hypothesized that NB-sup-treated DC could not stimulate iNKT cells sufficiently because only a small amount of IL-12 was secreted from NB-sup-treated DC. In contrast to our expectations, IFN-γ production in iNKT cells after stimulation with NLF-suptreated αGalCer-pulsed DC was reduced to only 70% on average of the level in control DC. Furthermore, in GOTO-sup-treated DC, IFN-γ production was decreased in only one of three donors ( Figure 6B ).
Tolerogenic DC expressed low levels of costimulatory molecules and high levels of co-inhibitory molecules. The differences in the expression of these molecules might have inhibited the secretion of IFN-γ by iNKT cells. By comparing the expressed molecules in NLF-supand GOTO-sup-treated DC, the former had lower levels of CD86 expression than the latter. Therefore, IFN-γ production in iNKT cells might have been suppressed after stimulation with NLF-sup-treated, αGalCer-pulsed DC but not after stimulation with GOTO-sup-treated αGalCer-pulsed DC.
We next analyzed the effect of IL-12 addition on iNKT cell stimulation with αGalCer-pulsed DC. The addition of exogenous IL-12 rescued IFN-γ production by iNKT cells when stimulated with NLF-sup-treated DC ( Figure 7A ). Moreover, inhibition of IL-12 downregulated IFN-γ production from ligand-activated iNKT cells ( Figure 7B ). However, data in 
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